Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Protalix BioTherapeutics Inc

+ Add to Watchlist

PLX:US

1.9300 USD 0.0400 2.03%

As of 10:49:35 ET on 02/27/2015.

Company Profile for Protalix BioTherapeutics Inc (PLX)

Protalix BioTherapeutics Inc. is a biotechnology company that has developed plant cell culture technology and a bioreactor system.

Contact Information

Protalix BioTherapeutics Inc

2 Snunit Street
Science Park PO Box 455
Carmiel, 20100
Israel
Phone: 972-4-988-9488
Fax: 972-4-988-9489

Key Executives for Protalix BioTherapeutics Inc (PLX)

Moshe ManorPresident/CEOTzvi PalashChief Operating Officer
Yoseph ShaaltielExec VP:Research & DevelopmentYossi MaimonVP/CFO/Treasurer/Secretary
Sandra L LauterbachVP:Sales & Commercial AffairsEinat Brill AlmonVP:Product Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil